Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

14.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.8K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

9.8K
9.8K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

566
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
566
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

188
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
188
Ligand Binding Sites02:40

Ligand Binding Sites

14.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.8K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

1.6K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From inflammation to neurodegeneration: an exploratory pilot study of a diagnostic framework for progression in MS.

Frontiers in neurology·2026
Same author

An Immuno-Infrared Sensor Detects Preclinical Alzheimer's and Parkinson's Disease by Protein Misfolding.

The journal of physical chemistry. B·2026
Same author

A Reversible ATR-FTIR Biosensor with Single-Residue Sensitivity.

Analytical chemistry·2026
Same author

Pushing the limits of hydrogen/deuterium exchange mass spectrometry to study protein:fragment low affinity interactions.

Communications chemistry·2025
Same author

Mechanistic insights into Ras-catalyzed GTP hydrolysis: conformational dynamics, catalytic mechanisms, and emerging therapeutic strategies.

Biological chemistry·2025
Same author

Discovery of ART5537: A Potent and Selective Small-Molecule Probe for EXO1.

Journal of medicinal chemistry·2025
Same journal

PFASGroups: An Open-Source Framework for Automated Identification, Structural Classification, and Prioritization of Per- and Polyfluoroalkyl Substances.

Journal of chemical information and modeling·2026
Same journal

DeepKbhb: Context-Aware Prediction of Human Lysine β-Hydroxybutyrylation Sites.

Journal of chemical information and modeling·2026
Same journal

HyperDC: A Non-Uniform Hypergraph Framework for Dual- and Higher-Order Drug Combination Recommendation Across Diverse Complex Diseases.

Journal of chemical information and modeling·2026
Same journal

Correction to "AstraMEV (AI-Guided Structural Assembly of Multi-Epitope Vaccines) Against Infectious Bronchitis Virus".

Journal of chemical information and modeling·2026
Same journal

MolPy: A Large Language Model-Friendly Toolkit for Reactive Topology Editing in Polymer Simulations.

Journal of chemical information and modeling·2026
Same journal

Molecular Mechanisms of KIT Receptor Dimerization and Oncogenic Activation Revealed by Multiscale Simulations.

Journal of chemical information and modeling·2026
See all related articles

Related Experiment Video

Updated: Jan 4, 2026

Determination of Protein-ligand Interactions Using Differential Scanning Fluorimetry
13:26

Determination of Protein-ligand Interactions Using Differential Scanning Fluorimetry

Published on: September 13, 2014

62.6K

Estimation of Protein-Ligand Unbinding Kinetics Using Non-Equilibrium Targeted Molecular Dynamics Simulations.

Steffen Wolf1,2, Marta Amaral3,4,5, Maryse Lowinski6

  • 1Department of Biophysics , Ruhr-University Bochum , 44780 Bochum , Germany.

Journal of Chemical Information and Modeling
|November 8, 2019
PubMed
Summary
This summary is machine-generated.

Nonequilibrium targeted molecular dynamics simulations accurately predict protein-ligand unbinding rates. Understanding molecular interactions along the unbinding pathway is key for designing effective small molecule ligands.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.1K
Measuring Biomolecular DSC Profiles with Thermolabile Ligands to Rapidly Characterize Folding and Binding Interactions
09:15

Measuring Biomolecular DSC Profiles with Thermolabile Ligands to Rapidly Characterize Folding and Binding Interactions

Published on: November 21, 2017

8.7K

Related Experiment Videos

Last Updated: Jan 4, 2026

Determination of Protein-ligand Interactions Using Differential Scanning Fluorimetry
13:26

Determination of Protein-ligand Interactions Using Differential Scanning Fluorimetry

Published on: September 13, 2014

62.6K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.1K
Measuring Biomolecular DSC Profiles with Thermolabile Ligands to Rapidly Characterize Folding and Binding Interactions
09:15

Measuring Biomolecular DSC Profiles with Thermolabile Ligands to Rapidly Characterize Folding and Binding Interactions

Published on: November 21, 2017

8.7K

Area of Science:

  • Computational chemistry
  • Biophysics
  • Drug discovery

Background:

  • Protein-ligand interactions are crucial for biological processes.
  • Estimating ligand unbinding kinetics is vital for drug development.
  • Current methods for predicting unbinding rates have limitations.

Purpose of the Study:

  • To evaluate nonequilibrium targeted molecular dynamics (TMD) simulations for predicting protein-ligand unbinding kinetics.
  • To correlate simulation data with experimental kinetics measurements.
  • To elucidate the molecular determinants of ligand unbinding rates.

Main Methods:

  • Nonequilibrium targeted molecular dynamics (TMD) simulations were performed.
  • Simulations were correlated with Surface Plasmon Resonance (SPR) kinetics data.
  • X-ray crystallography data was used for structural analysis.
  • Analysis focused on mean nonequilibrium work and molecular interactions.

Main Results:

  • The mean nonequilibrium work from TMD simulations is a promising predictor of ligand unbinding rates.
  • Ligand conformational changes and protein-ligand nonbonded interactions influence unbinding kinetics.
  • Strong electrostatic and van der Waals interactions can increase ligand residence time.
  • Transient electrostatic interactions can facilitate unbinding for rigid ligands.

Conclusions:

  • Nonequilibrium TMD simulations offer a valuable tool for estimating protein-ligand unbinding kinetics.
  • Understanding the unbinding pathway and interactions is critical for predicting ligand unbinding behavior.
  • This approach aids in the rational design of small molecules with desired unbinding kinetics.